Cargando…
Impact of Diabetes on Myocardial Fibrosis in Patients With Hypertension: The REMODEL Study
Compared with patients with hypertension only, those with hypertension and diabetes (HTN/DM) have worse prognosis. We aimed to characterize morphological differences between hypertension and HTN/DM using cardiovascular magnetic resonance; and compare differentially expressed proteins associated with...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351902/ https://www.ncbi.nlm.nih.gov/pubmed/37431660 http://dx.doi.org/10.1161/CIRCIMAGING.123.015051 |
_version_ | 1785074404925898752 |
---|---|
author | Pua, Chee Jian Loo, Germaine Kui, Michelle Moy, Wai Lun Hii, An-An Lee, Vivian Chin, Chee-Tang Bryant, Jennifer A. Toh, Desiree-Faye Lee, Chi-Hang Cook, Stuart A. Richards, A. Mark Le, Thu-Thao Chin, Calvin W.L. |
author_facet | Pua, Chee Jian Loo, Germaine Kui, Michelle Moy, Wai Lun Hii, An-An Lee, Vivian Chin, Chee-Tang Bryant, Jennifer A. Toh, Desiree-Faye Lee, Chi-Hang Cook, Stuart A. Richards, A. Mark Le, Thu-Thao Chin, Calvin W.L. |
author_sort | Pua, Chee Jian |
collection | PubMed |
description | Compared with patients with hypertension only, those with hypertension and diabetes (HTN/DM) have worse prognosis. We aimed to characterize morphological differences between hypertension and HTN/DM using cardiovascular magnetic resonance; and compare differentially expressed proteins associated with myocardial fibrosis using high throughput multiplex assays. METHODS: Asymptomatic patients underwent cardiovascular magnetic resonance: 438 patients with hypertension (60±8 years; 59% males) and 167 age- and sex-matched patients with HTN/DM (60±10 years; 64% males). Replacement myocardial fibrosis was defined as nonischemic late gadolinium enhancement on cardiovascular magnetic resonance. Extracellular volume fraction was used as a marker of diffuse myocardial fibrosis. A total of 184 serum proteins (Olink Target Cardiovascular Disease II and III panels) were measured to identify unique signatures associated with myocardial fibrosis in all patients. RESULTS: Despite similar left ventricular mass (P=0.344) and systolic blood pressure (P=0.086), patients with HTN/DM had increased concentricity and worse multidirectional strain (P<0.001 for comparison of all strain measures) compared to hypertension only. Replacement myocardial fibrosis was present in 28% of patients with HTN/DM compared to 16% of those with hypertension (P<0.001). NT-proBNP (N-terminal pro-B-type natriuretic peptide) was the only protein differentially upregulated in hypertension patients with replacement myocardial fibrosis and independently associated with extracellular volume. In patients with HTN/DM, GDF-15 (growth differentiation factor 15) was independently associated with replacement myocardial fibrosis and extracellular volume. Ingenuity Pathway Analysis demonstrated a strong association between increased inflammatory response/immune cell trafficking and myocardial fibrosis in patients with HTN/DM. CONCLUSIONS: Adverse cardiac remodeling was observed in patients with HTN/DM. The novel proteomic signatures and associated biological activities of increased immune and inflammatory response may partly explain these observations. |
format | Online Article Text |
id | pubmed-10351902 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-103519022023-07-18 Impact of Diabetes on Myocardial Fibrosis in Patients With Hypertension: The REMODEL Study Pua, Chee Jian Loo, Germaine Kui, Michelle Moy, Wai Lun Hii, An-An Lee, Vivian Chin, Chee-Tang Bryant, Jennifer A. Toh, Desiree-Faye Lee, Chi-Hang Cook, Stuart A. Richards, A. Mark Le, Thu-Thao Chin, Calvin W.L. Circ Cardiovasc Imaging Original Articles Compared with patients with hypertension only, those with hypertension and diabetes (HTN/DM) have worse prognosis. We aimed to characterize morphological differences between hypertension and HTN/DM using cardiovascular magnetic resonance; and compare differentially expressed proteins associated with myocardial fibrosis using high throughput multiplex assays. METHODS: Asymptomatic patients underwent cardiovascular magnetic resonance: 438 patients with hypertension (60±8 years; 59% males) and 167 age- and sex-matched patients with HTN/DM (60±10 years; 64% males). Replacement myocardial fibrosis was defined as nonischemic late gadolinium enhancement on cardiovascular magnetic resonance. Extracellular volume fraction was used as a marker of diffuse myocardial fibrosis. A total of 184 serum proteins (Olink Target Cardiovascular Disease II and III panels) were measured to identify unique signatures associated with myocardial fibrosis in all patients. RESULTS: Despite similar left ventricular mass (P=0.344) and systolic blood pressure (P=0.086), patients with HTN/DM had increased concentricity and worse multidirectional strain (P<0.001 for comparison of all strain measures) compared to hypertension only. Replacement myocardial fibrosis was present in 28% of patients with HTN/DM compared to 16% of those with hypertension (P<0.001). NT-proBNP (N-terminal pro-B-type natriuretic peptide) was the only protein differentially upregulated in hypertension patients with replacement myocardial fibrosis and independently associated with extracellular volume. In patients with HTN/DM, GDF-15 (growth differentiation factor 15) was independently associated with replacement myocardial fibrosis and extracellular volume. Ingenuity Pathway Analysis demonstrated a strong association between increased inflammatory response/immune cell trafficking and myocardial fibrosis in patients with HTN/DM. CONCLUSIONS: Adverse cardiac remodeling was observed in patients with HTN/DM. The novel proteomic signatures and associated biological activities of increased immune and inflammatory response may partly explain these observations. Lippincott Williams & Wilkins 2023-07-11 2023-07 /pmc/articles/PMC10351902/ /pubmed/37431660 http://dx.doi.org/10.1161/CIRCIMAGING.123.015051 Text en © 2023 The Authors. Circulation: Cardiovascular Imaging is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made. |
spellingShingle | Original Articles Pua, Chee Jian Loo, Germaine Kui, Michelle Moy, Wai Lun Hii, An-An Lee, Vivian Chin, Chee-Tang Bryant, Jennifer A. Toh, Desiree-Faye Lee, Chi-Hang Cook, Stuart A. Richards, A. Mark Le, Thu-Thao Chin, Calvin W.L. Impact of Diabetes on Myocardial Fibrosis in Patients With Hypertension: The REMODEL Study |
title | Impact of Diabetes on Myocardial Fibrosis in Patients With Hypertension: The REMODEL Study |
title_full | Impact of Diabetes on Myocardial Fibrosis in Patients With Hypertension: The REMODEL Study |
title_fullStr | Impact of Diabetes on Myocardial Fibrosis in Patients With Hypertension: The REMODEL Study |
title_full_unstemmed | Impact of Diabetes on Myocardial Fibrosis in Patients With Hypertension: The REMODEL Study |
title_short | Impact of Diabetes on Myocardial Fibrosis in Patients With Hypertension: The REMODEL Study |
title_sort | impact of diabetes on myocardial fibrosis in patients with hypertension: the remodel study |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351902/ https://www.ncbi.nlm.nih.gov/pubmed/37431660 http://dx.doi.org/10.1161/CIRCIMAGING.123.015051 |
work_keys_str_mv | AT puacheejian impactofdiabetesonmyocardialfibrosisinpatientswithhypertensiontheremodelstudy AT loogermaine impactofdiabetesonmyocardialfibrosisinpatientswithhypertensiontheremodelstudy AT kuimichelle impactofdiabetesonmyocardialfibrosisinpatientswithhypertensiontheremodelstudy AT moywailun impactofdiabetesonmyocardialfibrosisinpatientswithhypertensiontheremodelstudy AT hiianan impactofdiabetesonmyocardialfibrosisinpatientswithhypertensiontheremodelstudy AT leevivian impactofdiabetesonmyocardialfibrosisinpatientswithhypertensiontheremodelstudy AT chincheetang impactofdiabetesonmyocardialfibrosisinpatientswithhypertensiontheremodelstudy AT bryantjennifera impactofdiabetesonmyocardialfibrosisinpatientswithhypertensiontheremodelstudy AT tohdesireefaye impactofdiabetesonmyocardialfibrosisinpatientswithhypertensiontheremodelstudy AT leechihang impactofdiabetesonmyocardialfibrosisinpatientswithhypertensiontheremodelstudy AT cookstuarta impactofdiabetesonmyocardialfibrosisinpatientswithhypertensiontheremodelstudy AT richardsamark impactofdiabetesonmyocardialfibrosisinpatientswithhypertensiontheremodelstudy AT lethuthao impactofdiabetesonmyocardialfibrosisinpatientswithhypertensiontheremodelstudy AT chincalvinwl impactofdiabetesonmyocardialfibrosisinpatientswithhypertensiontheremodelstudy |